Previous Article | Next Article ![]()
Infection and Immunity, November 1998, p. 5534-5536, Vol. 66, No. 11
Institute of Infectious Diseases, University Hospital
Benjamin Franklin, Free University of Berlin, 12203 Berlin, Germany
Received 24 March 1998/Returned for modification 20 May
1998/Accepted 13 July 1998
Bartonella henselae is an emerging pathogen
causing cat scratch disease, bacillary angiomatosis, and peliosis
hepatis. Progress in understanding the pathogenesis of and the immune
response to these infections has been limited by the lack of an animal
model. Following intraperitoneal infection of C57BL/6 mice with
B. henselae, organs were cleared of cultivatable bacteria
within 6 days. In contrast, B. henselae DNA could be
detected in liver tissue for at least 3 months. Liver tissue showed
granulomatous inflammation reaching its highest degree of intensity
during the fourth week of infection and resolving within 12 weeks
postinfection. This mouse model is applicable to the study of the
pathogenesis of B. henselae and the immune response to this
pathogen in the immunocompetent host.
Bartonella henselae, a
gram-negative bacterium in the family Bartonellaceae, was
recently recognized to cause cat scratch disease (CSD), bacillary
angiomatosis (BA), peliosis hepatis, and persistent bacteremia
(13, 16, 17). CSD is a common cause of subacute regional
granulomatous lymphadenitis in immunocompetent persons (7).
In contrast, BA and peliosis hepatis, as well as bacteremia, occur most
commonly in individuals infected with the human immunodeficiency virus
(HIV). BA refers to a vasculoproliferative disease that often involves
the skin in the form of nodular lesions, but may disseminate to other
organs. Peliosis hepatis is characterized by vascular proliferation in
liver tissue resulting in blood-filled spaces and may be associated
with BA in HIV-infected patients (9). Progress in
understanding the pathogenesis of and the immune response to these
infections has been limited by the lack of a suitable animal model.
Recently, cats experimentally infected with B. henselae by
intravenous inoculation were shown to develop histopathologic lesions in multiple organs, including granulomas in liver and lymph nodes (6). Therefore cats might be used for studying infection
with B. henselae. However, because of the advantages rodents
offer for immunological investigation, we have developed a murine model of B. henselae infection.
B. henselae Houston 1 (ATCC 49882) recovered from the
bloodstream of an HIV-positive patient in 1992 (12) was used
throughout. To increase and maintain virulence in mice, initial in vivo
passages were performed as follows. Bacteria from a log-phase culture
in brucella broth (BBL Microbiology Systems, Cockeysville, Md.)
supplemented with hemin (250 µg/ml) and 8% Fildes solution
(14) and incubated at 37°C in 7% CO2 in air
were pelleted by centrifugation (5,000 × g, 30 min),
washed three times in phosphate-buffered saline, and administered
intraperitoneally (i.p.) to C57BL/6 mice in doses ranging from 5 × 107 to 5 × 108 CFU. After 3 days,
spleens were removed, homogenized, and inoculated into supplemented
brucella broth. On day 5 of incubation, the bacteria were harvested and
injected i.p. again. After completing a minimum of four in vivo
passages, bacteria grown from spleen homogenates were used for
infection experiments without prior freezing to ensure optimal
viability.
Female C57BL/6 and BALB/c mice raised in our breeding facilities were
used at the age of 10 to 12 weeks. All inoculations were performed i.p.
in a volume of 0.5 ml of phosphate-buffered saline. Inocula were
determined by plating of 10-fold serial dilutions on Columbia agar
(Oxoid, Basingstoke, United Kingdom) supplemented with 5% human blood.
Clearance of bacteria from infected organs.
To determine the
course of infection in C57BL/6 mice, 9.1 × 107 CFU of
viable bacteria were inoculated i.p. Groups of five animals each were
killed 6 h postinfection; daily from day 1 to day 6; and on days
10, 21, 36, 64, and 94. From all mice, bacterial loads in liver,
spleen, lung, kidney, and brain were determined by plating of 10-fold
serial dilutions of organ homogenates on Columbia agar supplemented
with 5% human blood. In addition, quantitative cultures of blood
specimens were performed at the time of necropsy. Before being plated
on Columbia agar, erythrocytes were lysed either by freezing and
thawing or by being mixed vigorously with distilled water. The
detection limits of these procedures were 10 bartonellae per organ and
1 bartonella per 0.25 ml of blood, respectively. All cultures were
incubated at 37°C in 7% CO2 in air for at least 3 weeks
before being coded as negative for growth. Colonies were identified as
B. henselae by colony morphology and Gram stain.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Murine Model of Bartonella
henselae Infection in the Immunocompetent Host
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References

View larger version (13K):
[in a new window]
FIG. 1.
C57BL/6 mice were infected i.p. with B. henselae. To determine the course of infection, bacterial loads in
livers and spleens were determined by culture. Nested PCR was performed
with samples of B. henselae DNA from culture-negative
livers. The cellular inflammatory reaction in liver tissue was
quantified by counting of mononuclear foci. (A) Following i.p.
inoculation with 9.1 × 107 CFU of B. henselae, cultivatable organisms were cleared from livers (
)
and spleens (
) of C57BL/6 mice within 4 and 6 days, respectively
(five animals per group, with each triangle or circle representing a
positive culture from a single organ). DNA from B. henselae
(
) could be detected in liver tissue for at least 3 months (with
each star representing three positive results from three mice). (B)
Kinetics of cellular inflammatory reaction in liver tissue following
i.p. inoculation with 1.2 × 108 CFU of B. henselae (three mice per group, with each circle representing a
single mouse). Mononuclear foci were counted from
hematoxylin-and-eosin-stained sections.
Detection of B. henselae DNA in liver tissue.
In
CSD, isolation of B. henselae from patients has been rare
(4). In contrast, detection of B. henselae DNA by
PCR could be achieved in clinical specimens from the majority of
patients (1, 15). To determine the presence of B. henselae DNA in mouse tissue, we developed a nested PCR assay to
amplify part of the B. henselae gltA gene (11).
The outer primer sequences were 5' GGT CCC AAC TCT TGC CGC TAT G 3' and
5' CAG CCG ACA CTG CGT GCT AAT G 3'. The sequences of the inner primers
were 5' ATG CCT AAA AAT GTT ACA AGA 3' and 5' CGT GCT AAT GCA AAA AGA
AC 3'. The sensitivity of PCR was 10 CFU per organ, which equals the sensitivity of culture. Liver homogenates of C57BL/6 mice infected with
9.1 × 107 viable B. henselae organisms
were analyzed by PCR. Mice were sacrificed at days 21, 36, 64, and 94. DNA from the livers of three animals each was extracted with a QIAamp
tissue kit (Qiagen, Hilden, Germany) according to the manufacturer's
protocol. Extracts were stored at
70°C. PCR was performed with
Taq polymerase (InViTek, Berlin, Germany) in a volume of 25 µl in two sequential tubes. Following initial denaturation for 4 min
at 95°C, amplification with outer primers was performed with 30 cycles of 1 min at 94°C, 1 min at 70°C, and 2 min at 72°C.
Amplification with inner primers consisted of 30 cycles of 1 min at
94°C, 10 s at 30°C, and 1 min at 72°C. The final extension
step was extended to 10 min in both rounds of PCR. Positive controls
were obtained by spiking of liver tissue homogenate from an uninfected
mouse with B. henselae prior to DNA extraction. DNA from the
liver of an uninfected mouse was used as a negative control. Numerous
negative controls were included to exclude cross-contamination. The
reaction product was visualized by electrophoresis in an agarose gel
and by staining with ethidium bromide. The expected product size was
354 bp. PCR was repeated twice for two separately prepared DNA samples.
Nested PCR for the gltA gene revealed the presence of
B. henselae DNA for at least 3 months in the livers of all
mice examined. This result indicates the presence of B. henselae in liver tissue.
Histopathology. Bartonella-induced histopathological alterations were determined for C57BL/6 mice infected with inocula ranging from 5 × 105 to 8.5 × 108 viable B. henselae organisms. Animals were killed at different times up to day 94 postinfection. From three animals per group, sections of formalin-fixed liver, spleen, lung, kidney, and brain tissue were stained with hematoxylin and eosin. Because granulomas characteristically contain mainly CD4+ T cells and monocyte-derived CD11b+ cells, tissue sections showing accumulations of mononuclear cells were analyzed immunohistochemically. Frozen liver sections were stained with rat anti-mouse anti-CD4 (10), anti-CD8 (10), or anti-CD11b (3) monoclonal antibodies as the primary antibodies and peroxidase-conjugated goat anti-rat immunoglobulin G (Dianova, Hamburg, Germany) as the secondary antibody. Color was developed with diaminobenzidine and hydrogen peroxide as a substrate. Negative controls were free of artifacts due to endogenous peroxidase activity.
Inoculation with at least 5 × 107 organisms reproducibly showed the following course of tissue reaction. Beginning at day 3 postinfection, liver tissue showed a few small aggregates of lymphocytes and monocytes that expanded in size and number over the next few days. During the second week, granulomatous lesions, consisting of lymphocytes, monocytes, and epithelioid cells, became more obvious. Granulomatous lesions expanded in size and number until reaching maximal density during the fourth week of infection, when up to 130 randomly distributed mononuclear foci were counted per 0.25 cm2 in liver sections (Fig. 2A). Mononuclear cells were predominantly CD4+ lymphocytes (Fig. 2B) or CD11b+ monocytes (Fig. 2C). CD8+ lymphocytes were found in low numbers. They were located mainly in the periphery (not shown). Two weeks later, a marked reduction of inflammatory lesions was observed, and at the end of the third month postinfection, liver tissue was completely devoid of inflammatory lesions (Fig. 1B). The other organs investigated did not show significant lesions at any time. Inocula from 5 × 106 to 5 × 107 CFU caused a similar course of inflammation in liver tissue. The density of infiltrates, however, was markedly lower, and there was more variation in numbers of infiltrates between mice of a group than in mice infected with higher inocula. Inocula lower than 5 × 106 CFU did not cause significant tissue reactions (data not shown).
|
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Institute of Infectious Diseases, University Hospital Benjamin Franklin, Free University of Berlin, Hindenburgdamm 27, D-12203 Berlin, Germany. Phone: 49 30 8445 3620. Fax: 49 30 8445 3830. E-mail: regnath{at}zedat.fu-berlin.de.
Editor: J. R. McGhee
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Avidor, B., Y. Kletter, S. Abulafia, Y. Golan, M. Ephros, and M. Giladi. 1997. Molecular diagnosis of cat scratch disease: a two-step approach. J. Clin. Microbiol. 35:1924-1930[Abstract]. |
| 2. | Cockerell, J. C., and D. H. Connor. 1979. Cat scratch disease, p. 461-468. In D. H. Connor, F. W. Chandler, D. A. Schwartz, H. J. Manz, and E. E. Lack (ed.), Pathology of infectious diseases. Appleton & Lange, Stamford, Conn. |
| 3. | Dobrick, P., K. Miksits, and H. Hahn. 1995. L3T4(CD4)-, Lyt-2(CD8)- and Mac-1(CD11b)-phenotypic leukocytes in murine cryptococcal meningoencephalitis. Mycopathologia 131:159-166[Medline]. |
| 4. |
Dolan, M. J.,
M. T. Wong,
R. L. Regnery,
J. H. Jorgensen,
M. Garcia,
J. Peters, and D. Drehner.
1993.
Syndrome of Rochalimaea henselae adenitis suggesting cat scratch disease.
Ann. Intern. Med.
118:331-336 |
| 5. | Dunn, P. L., and R. J. North. 1995. Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice. Infect. Immun. 63:3428-3437[Abstract]. |
| 6. | Guptill, L., L. Slater, C. C. Wu, T. L. Lin, L. T. Glickman, D. F. Welch, and H. HogenEsch. 1997. Experimental infection of young specific pathogen-free cats with Bartonella henselae. J. Infect. Dis. 176:206-216[Medline]. |
| 7. |
Jackson, L. A.,
B. A. Perkins, and J. D. Wenger.
1993.
Cat scratch disease in the United States: an analysis of three national databases.
Am. J. Public Health
83:1707-1711 |
| 8. | Mackaness, G. B. 1962. Cellular resistance to infection. J. Exp. Med. 116:381-406[Abstract]. |
| 9. | Maurin, M., R. Birtles, and D. Raoult. 1997. Current knowledge of Bartonella species. Eur. J. Clin. Microbiol. Infect. Dis. 16:487-506[Medline]. |
| 10. |
Mielke, M. E.,
S. Ehlers, and H. Hahn.
1988.
T-cell subsets in delayed-type hypersensitivity, protection, and granuloma formation in primary and secondary Listeria infection in mice: superior role of Lyt-2+ cells in acquired immunity.
Infect. Immun.
56:1920-1925 |
| 11. | Norman, A. F., R. Regnery, P. Jameson, C. Greene, and D. C. Krause. 1995. Differentiation of Bartonella-like isolates at the species level by PCR-restriction fragment length polymorphism in the citrate synthase gene. J. Clin. Microbiol. 33:1797-1803[Abstract]. |
| 12. |
Regnery, R. L.,
B. E. Anderson,
J. E. Clarridge III,
M. C. Rodriguez-Barradas,
D. C. Jones, and J. H. Carr.
1992.
Characterization of a novel Rochalimaea species, R. henselae sp. nov., isolated from blood of a febrile, human immunodeficiency virus-positive patient.
J. Clin. Microbiol.
30:265-274 |
| 13. | Regnery, R. L., J. G. Olson, B. A. Perkins, and W. Bibb. 1992. Serological response to "Rochalimaea henselae" antigen in suspected cat-scratch disease. Lancet 339:1443-1445[Medline]. |
| 14. |
Schwartzman, W. A.,
C. A. Nesbit, and E. J. Baron.
1993.
Development and evaluation of a blood-free medium for determining growth curves and optimizing growth of Rochalimaea henselae.
J. Clin. Microbiol.
31:1882-1885 |
| 15. | Scott, M. A., T. L. McCurley, J. C. Vnencak, C. Hager, J. A. McCoy, B. Anderson, R. D. Collins, and K. M. Edwards. 1996. Cat scratch disease: detection of Bartonella henselae DNA in archival biopsies from patients with clinically, serologically, and histologically defined disease. Am. J. Pathol. 149:2161-2167[Abstract]. |
| 16. |
Slater, L. N.,
D. F. Welch, and K. W. Min.
1992.
Rochalimaea henselae causes bacillary angiomatosis and peliosis hepatis.
Arch. Intern. Med.
152:602-606 |
| 17. |
Zangwill, K. M.,
D. H. Hamilton,
B. A. Perkins,
R. L. Regnery,
B. D. Plikaytis,
J. L. Hadler,
M. L. Cartter, and J. D. Wenger.
1993.
Cat scratch disease in Connecticut. Epidemiology, risk factors, and evaluation of a new diagnostic test.
N. Engl. J. Med.
329:8-13 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»